Dr. William Kovalczyk, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 148 Mission Oak Dr, Grayson, GA 30017 Phone: 678-376-5714 |
Primary Foot & Ankle Care Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 862 Amber Hill Ct, Grayson, GA 30017 Phone: 770-513-3556 Fax: 770-513-3556 |
News Archive
No one wants antibiotic residues in their milk. But antibiotics are sometimes used even in the dairy barn. The routine tests conducted nowadays take hours to produce a result and do not test for all of the typical antibiotics. This gap can now be closed, thanks to a fully automated minilab developed by scientists from the TUM in cooperation with the LMU Muenchen and gwk Praezisionstechnik GmbH.
A natural, non-toxic byproduct of glucose may prevent brain cell death and cognitive impairment in diabetics following an episode of severely low blood sugar, according to researchers at the San Francisco VA Medical Center (SFVAMC).
Healthy people with high blood pressure who excrete a slight excess of protein in the urine raise their risk of developing kidney and heart complications. According to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN), more attention should focus on the potential health effects of urinary protein excretion in individuals with high blood pressure (hypertension).
Custom Mechanical Systems (CMS), a leading provider of custom cooling/HVAC solutions for mission-critical facilities, including data centers, laboratories, cleanrooms and hospitals, today announces the new CMS InRack and CRAC Cooling Systems for data centers looking to achieve upwards of 40% energy savings. Unlike mass-produced antiquated fan-based cooling products, the CMS cooling systems are customized for each data center project and include the most technologically advanced fan design on the market today.
Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders, which is being conducted in collaboration with Pfizer. As previously reported, the companies recently selected a candidate compound to advance into further clinical studies. Dosing of this candidate compound has now been initiated in a Phase I study in healthy volunteers.
› Verified 4 days ago